Respiratory and reproductive vaccines that provide cattle critical coverage.
BOVILIS VISTA vaccines strengthen the immune system of breeding females while also setting calf crops up for success.
With these vaccines, you can count on increased productivity due to less vaccination stress, leading to healthier cattle and higher profits.1 BOVILIS VISTA has also been extensively researched with industry-leading data on respiratory duration of immunity.2-5
Could your calves be more covered from BRD?
If you’re not using Bovilis® Vista® Once SQ – shown effective against Pasteurella multocida and BVD Type 1b – the answer is “yes.”
Give calves the most comprehensive BRD vaccine. No other covers as much.6
BOVILIS VISTA ONCE SQ is the only injectable cattle vaccine that demonstrates efficacy against five viral causes and two bacterial causes of respiratory disease – shown effective against Pasteurella multocida and BVD Type 1b.
All with industry-leading duration of immunity, plus the lowest endotoxin load on the market for less vaccination stress.7,8
Pasteurella multocida is on the rise. Which puts ADG on the decline.
P. multocida:
- Lives within calves normally, just waiting for an opportunity when health is compromised by stress, viruses or parasites
- Is the second most common disease-causing germ found in beef cattle samples collected at midwestern labs9
- Has been shown to cause rapid and permanent tissue damage (lesions), leading to animals being less productive10
- Antimicrobial resistance is common, making treatment difficult and vaccination the first line of defense9
Shown effective against BVD Type 1b
BVD Type 1b:
- Is the most prevalent subtype in the U.S. and accounts for more than two-thirds of all BVD-positive cattle11
- Be sure to select a vaccine that provides effectiveness against 1b
- Vaccination with common types and subtypes is essential to prevent gaps in coverage
Big-time vaccine. Low endotoxin load.
Higher endotoxin levels can lead to vaccine sweat in cattle post-vaccination. This can limit the number of antigens given at a time. The technology behind BOVILIS VISTA ONCE SQ means you get the most complete BRD vaccine available in a single dose with the lowest endotoxin levels to support both the health of your herd and the bottom line.7,8
BOVILIS® VISTA®: Addressing Emerging Diseases
Innovation is critical in vaccine development. Merck Animal Health has a history of finding a better way forward through game-changing advancements, and today offers one of the most complete vaccine portfolios. Learn about BOVILIS® VISTA® from members of the team who brought it to market.
See the complete BOVILIS VISTA lineup.
With fewer reactions for higher productivity, BOVILIS VISTA set and continues to set the industry standard for respiratory and reproductive protection.
Shown effective for the vaccination of healthy cattle 3 months of age or older against respiratory disease and abortion due to infectious bovine rhinotracheitis (IBR), respiratory disease and fetal infection, including persistently infected calves due to bovine virus diarrhea virus (BVD) Types 1 and 2, bovine respiratory syncytial virus (BRSV) and parainfluenza3 virus (PI3).
Shown effective for the vaccination of healthy cattle 6 months of age or older against respiratory disease and abortion due to infectious bovine rhinotracheitis (IBR), respiratory disease and fetal infection, including persistently infected calves due to bovine virus diarrhea virus (BVD) Types 1 & 2, bovine respiratory syncytial virus (BRSV), parainfluenza3 virus (PI3) and leptospirosis.
Shown to be effective for the vaccination of healthy cattle 3 months of age or older against respiratory disease and abortion due to infectious bovine rhinotracheitis (IBR), respiratory disease and fetal infection, including persistently infected calves due to bovine virus diarrhea virus (BVD) Types 1 and 2, bovine respiratory syncytial virus (BRSV), parainfluenza3 virus (PI3), Mannheimia Haemolytica and Pasteurella multocida.
Shown to be effective for the vaccination of healthy cattle, 3 months of age or older against respiratory disease and fetal infection, including persistently infected calves due to bovine virus diarrhea virus (BVD) Types 1 and 2.
Shown to be effective for the vaccination of healthy cattle 3 months of age or older against respiratory disease and abortion due to infectious bovine rhinotracheitis (IBR), respiratory disease and fetal infection, including persistently infected calves due to bovine virus diarrhea virus (BVD) Types 1 and 2, bovine respiratory syncytial virus (BRSV), parainfluenza3 virus (PI3), Mannheimia Haemolytica and Pasteurella multocida.
No matter the need, Merck Animal Health has the right BRD solution for the situation.
Stay in front of profit-robbing diseases with the comprehensive vaccine lineup from Merck Animal Health.
Get the latest updates! Sign up to receive cattle health management insights, industry news and more sent straight to your inbox.
References
*All trademarks are property of their respective owners.
1. Effects of Vaccination with Vista® 5 L5 SQ or Bovi-Shield GOLD® FP® L5 on Milk Production. 2010.
2. Purtle L, et al. One Year Duration of Immunity of the Modified Live Bovine Viral Diarrhea Virus Type 1 and Type 2 and Bovine Herpesvirus-1 Fractions of Vista® Once SQ Vaccine. Vaccine. 2016;34(13):1582-1588.
3. Report No. BRL-016R. Duration of Immunity in Calves for the Pasteurella multocida Fraction in Bovine Rhinotracheitis-Virus Diarrhea Parainfluenza 3-Respiratory Syncytial Virus – Mannheimia haemolytica Pasteurella multocida Vaccine, Modified Live Virus, A Virulent Live Culture. August 23, 2013.
4. Platt R, Burdett W, Roth JA. Introduction of antigen-specific T-cell subset activation to bovine respiratory disease viruses by a modified-live virus vaccine. Am J Vet Res. 2006;67:1179-1184.
5. See product label for information on access to safety and efficacy study summaries. 6. Based on product labels.
7. Jacobsen S, Toelboell T, Andersen PH. Dose dependency and individual variability in select clinical, haematological and blood biochemical responses after systemic lipopolysaccharide challenge in cattle. Vet Res. 2005;36:167-178.
8. Andersen PH. Bovine Endotoxin. Some aspects of relevance to production diseases. A Review. Acta Vet Scand Suppl. 2003;98:141-155.
9. Merck Animal Health Final Study Report. MS-MDR-KSU-1-14. 2015 surveillance of antimicrobial resistance in bovine respiratory pathogens isolated from U.S. cattle.
10. Nickunen S, Hartel H, Orro T, et al. Association of bovine disease with clinical status and acute phase proteins in calves. Comp Immun and Micro Infect Dis. 2007;30:143-151.
11. Fulton RW, Ridpath JF, Saliki JT, et al. Bovine viral diarrhea virus (BVDV) 1b: predominant BVDV subtype in calves with respiratory disease. Can J Vet Res. 2002;66(3):181-190.